IP Library Granted Patent US 9,957,283
Granted Patent B1
US 9,957,283 · App. 15/784,585 · Granted May 1, 2018

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,957,283
App. No.
15/784,585
Granted
May 1, 2018
Kind
B1
Abstract

Novel processes, and intermediates, for making alkylated arylpiperazine and alkylated arylpiperidine compounds of the general formulas (I) and (VII), respectively wherein, R 1 and R 2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR 3 R 4 , OR 5 , or SR 5 , where R 3 and R 4 are individually selected from acyl or sulfonyl, and where R 5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.

Claims (39)

1. A method of preparing

wherein

Y is selected from the group consisting of

and

Ar is selected from the group consisting of

provided that when Y is

then Ar is

or when Y is

then Ar is

or when Y is

then Ar is

comprising

(i) alkylating 1,3,2-dioxathiane 2,2-dioxide having the formula

with

in the presence of base selected from potassium carbonate, sodium carbonate, magnesium carbonate, calcium carbonate, potassium hydroxide, sodium hydroxide, magnesium hydroxide or calcium hydroxide, to form the corresponding alkylation compound of the formula

wherein Q is potassium, sodium, magnesium or calcium,

(ii) hydrolyzing the alkylation compound of step (i) with aqueous acid to obtain the corresponding hydroxyl compound of formula

wherein Y is selected from the group consisting of

(iii) converting the compound of formula

of step (ii) to the corresponding alkylating agent compound of formula

wherein LG is an aryl sulfonate or alkyl sulfonate, and

(iv) alkylating the compound of formula

of step (iii) with the compound of formula

wherein Ar is selected from the group consisting of

in the presence of base selected from potassium carbonate, sodium carbonate, magnesium carbonate, calcium carbonate, potassium hydroxide, sodium hydroxide, magnesium hydroxide or calcium hydroxide,

provided that when Y is

then Ar is

or when Y is

then Ar is

or when Y is

then Ar is

2. The process of claim 1 wherein the base of steps (i) and (iv) is potassium carbonate.

3. The process of claim 1 wherein LG is methylsulfonate.

4. The process of claim 1 wherein Y is

and Ar is

5. The process of claim 1 wherein Y is

and Ar is

6. The process of claim 1 wherein Y is

and Ar is

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2022
From: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
To: MACFARLAN SMITH LIMITED
Reel/Frame 061888/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2022
From: COLLIER, STEVEN
To: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
Reel/Frame 059809/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2022
From: COUGHLIN, DANIEL J.; WILT, JEREMY C.; GOU, DA-MING
To: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
Reel/Frame 059523/0163 →